Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | -53 | 437 | 416 | 68,566 | 354 |
| Cost of Goods | N/A | N/A | N/A | N/A | 354 |
| Gross Profit | -53 | 437 | 416 | N/A | N/A |
| Operating Expenses | 1,720 | 2,909 | 3,083 | 20,124 | 14,873 |
| Operating Income | -1,773 | -2,472 | -2,667 | 48,442 | -14,519 |
| Interest Expense | 20 | 45 | 50 | 0 | 0 |
| Other Income | 359 | 103 | 407 | 11 | -112 |
| Pre-tax Income | -1,434 | -2,414 | -2,310 | 48,453 | -14,631 |
| Net Income Continuous | -1,434 | -2,414 | -2,310 | 48,453 | -14,631 |
| Net Income Discontinuous | -1,944 | N/A | -1,293 | 29,249 | -14,334 |
| Net Income | $-3,378 | $-2,414 | $-3,603 | $77,702 | $-28,965 |
| EPS Basic Total Ops | -0.32 | -0.24 | -0.37 | 8.41 | -3.13 |
| EPS Basic Continuous Ops | -0.13 | -0.24 | -0.24 | 5.48 | -1.58 |
| EPS Basic Discontinuous Ops | -0.18 | N/A | -0.13 | 2.93 | -1.55 |
| EPS Diluted Total Ops | -0.32 | -0.24 | -0.37 | 7.96 | -3.13 |
| EPS Diluted Continuous Ops | -0.13 | -0.24 | -0.24 | 5.47 | -1.58 |
| EPS Diluted Discontinuous Ops | -0.18 | N/A | -0.13 | 2.48 | -1.55 |
| EBITDA(a) | $-1,644 | $-2,343 | $-2,640 | $48,751 | $-14,246 |